Truist Securities Maintains Hold on Nevro, Lowers Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter maintains a Hold rating on Nevro (NYSE:NVRO) and lowers the price target from $32 to $30.
June 06, 2023 | 1:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities maintains a Hold rating on Nevro and lowers the price target from $32 to $30.
The news directly mentions Nevro and the lowered price target by Truist Securities. This may cause some investors to reconsider their positions, but the Hold rating suggests that the overall outlook remains neutral. The impact on the stock price is likely to be limited in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100